Mark Bodmer - 11 Sep 2023 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
CSO, President of R&D
Signature
/s/ Marella Thorell, Attorney-in-Fact for Mark Bodmer
Issuer symbol
EVLO on OTC
Transactions as of
11 Sep 2023
Net transactions value
$0
Form type
4
Filing time
13 Sep 2023, 20:55:17 UTC
Previous filing
09 Aug 2023
Next filing
03 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Restricted Stock Units Award $0 +37,500 $0.000000 37,500 11 Sep 2023 Common Stock 37,500 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2 The RSUs vest in three (3) substantially equal installments on each of November 1, 2023, February 1, 2024 and May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. These RSUs have no expiration date.